BRAF and melanoma: Interestingly, the potential efficacy of ICIs in Asian patients with BRAF V600-mutant melanoma may be limited by lower TMB, which is associated with reduced UV exposure and Fitzpatrick skin types III–IV, commonly observed in the Japanese population [50].